Low-magnitude high-frequency vibration (LMHFV) enhances bone remodeling in osteoporotic rat femoral fracture healing

Journal of Orthopaedic Research

Volumn 29, Issue 5, 2011, Pages 746-752

  Chow, Dick Ho Kiu ^a   Leung, Kwok Sui ^a   Qin, Ling ^a   Leung, Andraay Hon Chi ^a   Cheung, Wing Hoi ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

bisphosphonate; fracture healing; osteoporosis; remodeling; vibration

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5B; IBANDRONIC ACID; OSTEOCALCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE REMODELING; CALLUS; CONTROLLED STUDY; FEMALE; FEMUR FRACTURE; FEMUR FRACTURE HEALING; FRACTURE HEALING; HISTOPATHOLOGY; LOW MAGNITUDE HIGH FREQUENCY VIBRATION; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; TREATMENT DURATION; VIBRATION;

ANIMALS; BONE REMODELING; BONY CALLUS; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; OSTEOCALCIN; OSTEOCLASTS; OSTEOPOROTIC FRACTURES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VIBRATION; X-RAY MICROTOMOGRAPHY;

EID: 79952787457     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21303     Document Type: Article

References (29)

1. Leung KS, Shi HF, Cheung WH, et al. 2009. Low-magnitude high-frequency vibration accelerates callus formation, mineralization, and fracture healing in rats. J Orthop Res 27: 458-465.
2. Shi HF, Cheung WH, Qin L, et al. 2010. Low-magnitude high-frequency vibration treatment augments fracture healing in ovariectomy-induced osteoporotic bone. Bone 46: 1299-1305.
3. Rubin C, Turner AS, Bain S, et al. 2001. Anabolism. Low mechanical signals strengthen long bones. Nature 412: 603-604. (Pubitemid 32772264)
4. Gusi N, Raimundo A, Leal A., 2006. Low-frequency vibratory exercise reduces the risk of bone fracture more than walking: a randomized controlled trial. BMC Musculoskelet Disord 7: 92.
5. Schindeler A, McDonald MM, Bokko P, et al. 2008. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 19: 459-466.
6. Sims NA, Gooi JH., 2008. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 19: 444-451.
7. Matsuo K, Irie N., 2008. Osteoclast-osteoblast communication. Arch Biochem Biophys 473: 201-209.
8. Martin T, Gooi JH, Sims NA., 2009. Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr 19: 73-88.
9. Schell H, Lienau J, Epari DR, et al. 2006. Osteoclastic activity begins early and increases over the course of bone healing. Bone 38: 547-554.
10. Papapoulos SE., 2008. Bisphosphonates: how do they work ? Best Pract Res Clin Endocrinol Metab 22: 831-847.
11. Russell RGG., 2007. Bisphosphonates: mode of action and pharmacology. Pediatrics 119 (Suppl 2): S150-S162. (Pubitemid 46397937)
12. Russell RGG., 2006. Ibandronate: pharmacology and preclinical studies. Bone 38: S7-S12.
13. Bauss F, Russell RG., 2004. Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing. Osteoporos Int 15: 423-433. (Pubitemid 38843169)
14. Erben RG., 1997. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45: 307-314.
15. Leung KS., 2008. A practical manual for musculoskeletal research. Singapore: World Scientific Publishing Company.
16. Einhorn TA, Simon SR., 2000. Orthopaedic basic science: biology and biomechanics of the musculoskeletal system, 2nd ed. Rosemont, IL: American Academy of Orthopaedic Surgeons.
17. Naylor KE, Eastell R., 2006. Measurement of biochemical markers of bone formation. In:, Seibel MJ, Robins SP, Bilezikian JP, editors. Dynamics of bone and cartilage metabolism, 2nd ed. Burlington: Academic Press; p 529-540.
18. Kraenzlin ME, Seibel MJ., 2006. Measurement of biochemical markers of bone resorption. In:, Seibel MJ, Robins SP, Bilezikian JP, editors. Dynamics of bone and cartilage metabolism, 2nd ed. Burlington: Academic Press; p 541-563.
19. Wu Y, Lee JW, Uy L, et al. 2009. Tartrate-resistant acid phosphatase (tracp 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the bonetrapækit assay. J Pharm Biomed Anal 49: 1203-1212.
20. Little DG, Ramachandran M, Schindeler A., 2007. The anabolic and catabolic responses in bone repair. J Bone Joint Surg Br 89: 425-433. (Pubitemid 46851119)
21. McDonald MM, Dulai S, Godfrey C, et al. 2008. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. Bone 43: 653-662.
22. Peter CP, Cook WO, Nunamaker DM, et al. 1996. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res 14: 74-79. (Pubitemid 26091605)
23. Xie L, Jacobson JM, Choi ES, et al. 2006. Low-level mechanical vibrations can influence bone resorption and bone formation in the growing skeleton. Bone 39: 1059-1066. (Pubitemid 44550100)
24. Lau E, Al-Dujaili S, Guenther A, et al. 2010. Effect of low-magnitude, high-frequency vibration on osteocytes in the regulation of osteoclasts. Bone 46: 1508-1515.
25. Sun JS, Hong RC, Chang WH, et al. 2001. In vitro effects of low-intensity ultrasound stimulation on the bone cells. J Biomed Mater Res 57: 449-456. (Pubitemid 32885276)
26. Weinstein RS, Roberson PK, Manolagas SC., 2009. Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 360: 53-62.
27. Glowacki J., 2009. The deceiving appearances of osteoclasts. N Engl J Med 360: 80-82.
28. Jain N, Weinstein RS., 2009. Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challenges. Nat Rev Rheumatol 5: 341-346.
29. Chu P, Chao TY, Lin YF, et al. 2003. Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis 41: 1052-1059. (Pubitemid 36532140)